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: CE effector proteins demonstrate mixed proteolytic activities; related to Figure 1 A) Sequence alignment for the N-terminal accessory domains of SseL, ElaD, and ShiCE. Agreement in secondary structure prediction calculated for each individual sequence is shown above. B) Sequence alignment used to identify the putative catalytic Cys in bacterial CE enzymes (marked by an asterisk) by similarity to eukaryotic CE examples. C) Normalized FP measured as a function of time, as in Figure 1E , following addition of the well-studied SUMO-specific human SENP1 and NEDD8-specific human NEDP1. D) As in C for YopJ and AvrA in the presence of excess activator IP6. E) Suicide probe reaction, as in Figure 1C , monitoring reactivity of untagged YopJ and AvrA toward the indicated Ub/Ubl probes following 1 h incubation at room temperature (propargylamine-derived probes). F) As in C for untagged YopJ. G) 1 H, 15 N-HSQC TROSY spectra  of 80µM 15 N-labeled Ub alone (black) and in the presence of 1 molar equivalent of AvrA (80µM, red). Inset, enlarged region of the spectral overlay with Ub resonance assignments labeled. H) Autoradiography monitoring isotope incorporation following a 2 h incubation of each protein with 14 C-labeled Acetyl-CoA in the presence of IP6. Compare signal in wild-type over inactive mutant background (see Supplemental Experimental Procedures). I) Time course monitoring cleavage of pro-NEDD8 (81 aa) to the mature form (76 aa), for the dual-specific ChlaDUB1, NEDD8-specific NEDP1, and Ub-specific SseL. This demonstrates that, like other CE proteases, ChlaDUB1 possesses both peptidase and isopeptidase activities. J) Time course monitoring cleavage of NEDDylated Cul1 C-terminal domain (CTD, modified at Lys720) in the presence of ChlaDUB1, and NEDP1 or COP9 signalosome (CSN) as negative and positive controls, respectively. Although ChlaDUB1 and NEDP1 can remove some NEDD8 modifications (e.g., CTD-(NEDD8)2), only the specialized CSN protease can remove the regulatory NEDD8 modification from Cul1 (CTD-NEDD8). K) Linkage specificity analysis for all diUb substrates, as in Figure 1F , for SseL and ChlaDUB1 at 10-fold higher enzyme concentration. L) Linkage specificity analysis for all diUb substrates, as in Figure 1F , for LegCE, YopJ, and AvrA. M) As in L for YopJ and AvrA in the presence of activator IP6. Figure S2 : Structural analysis of bacterial CE deubiquitinases Table 1 A) Full asymmetric unit (ASU) of the 2.7Å SseL (24-340) crystal structure showing a 2|Fo|-|Fc| electron density map contoured at 1σ, and superposition of the two copies in the ASU. Crystallization of this construct depended upon an N-terminal His-tag, which makes crystal contacts in one molecule and forms a short helix against the Nterminal domain in another. Most likely resulting from these crystal contacts at the N-terminus, the two molecules in the ASU show deviation within the N-terminal domain (1.99Å Cα RMSD for residues 24-136), but overlay well in the catalytic domain (0.39Å Cα RMSD for residues 154-340). SseL is colored in shades of teal, ordered regions of the His-tag are colored in grey. B) Full ASU of the 2.1Å ChlaDUB1 (130-401) structure showing 2|Fo|-|Fc| electron density contoured at 1σ. The first ~20 residues form a highly extended structure via crystal contacts. C) Full ASU of the 2.4Å RickCE (420-691) crystal structure, along with a 2|Fo|-|Fc| electron density map contoured at 1σ, and an alignment of the two copies in the ASU. The two identical molecules in the ASU (0.27Å Cα RMSD) are interlaced by a large insertion forming a helical arm. D) Active site Cys, His, Asn, and Gln of SseL (teal) are shown. E) K63 diUb cleavage assay using wild-type and catalytic mutants of SseL. Table 1 A) Catalytically inactive XopD +VR-1 C470A tested against the Ub and tSUMO suicide probes following a 1 h incubation at room temperature (propargylamine-derived probes). Open arrow, unmodified. B) Close-up of the XopD~Ub covalent linkage, showing XopD catalytic triad residues and 2|Fo|-|Fc| electron density of the Ub Cterminus, contoured at 1σ. C) As in B, for the XopD~tSUMO complex. D) Superposition of the four XopD~Ub molecules present in the ASU. E) Superposition of XopD from its apo (PDB 2OIV), Ub-bound, and tSUMObound structures. VR-1 is not shown for clarity. F) Close-up of the tract leading into the XopD active site. Cterminal residues for Ub and tSUMO are shown above, and their positions within the XopD-bound structures is depicted below. G) 1 H, 15 N-HSQC TROSY spectra of 80µM 15 N-labeled Ub alone (black) and in the presence of 0.5 (40µM, red), 1 (80µM, blue), or 1.8 (144µM, green) molar equivalents of XopD +VR-1 (298-515). H) As in G, for 1.8 (144µM, magenta) molar equivalents of XopD ∆VR-1 (335-515). I) Resonances significantly perturbed in G by either line broadening or chemical shift perturbation mapped onto the XopD~Ub crystal structure (red). Prolines and other resonances missing from the NMR spectrum are shown in black. 
Active Site G587 G587 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 L586 C628 RickCE Active Site Figure 2E , for the SdeA crystal structure (PDB 5CRA). C) Suicide probe assay showing XopD +VR-1 (298-335) reaction with Ub, NEDD8, and NEDD8 A72R probes at room temperature for 1 h (chloroethylamine-derived probes) Open arrow, unmodified; closed arrow, modified. D) Close-up of the conserved hydrophobic S1' sites of ChlaDUB1 and RickCE. A) Induced SPI-2 T3SS secretion of cultured S. Typhimurium strains expressing 2HA-tagged wild-type or mutant SseL, in the ∆sseL or ∆ssaV (SPI-2 T3SS null) background. Secreted and pellet fractions were separated by SDS-PAGE and immunoblotted for HA (SseL), SseB (SPI-2 T3SS translocon protein), and DnaK (intracellular control protein).
Supplemental Experimental Procedures:
Cloning and molecular biology SseL, ElaD, and LegCE were cloned from the genomic DNA of Salmonella Typhimurium (strain LT2), Escherichia coli (serotype O157:H7), and Legionella pneumophila (strain Philadelphia, kind gift from C. Buchrieser, Institut Pasteur) using Phusion DNA polymerase (NEB). Genes encoding Chlamydia trachomatis ChlaDUB1, Shigella flexneri ShiCE, Rickettsia bellii RickCE, and Xanthomonas campestris XopD were obtained by gene synthesis (Life Technologies) and subcloned using KOD polymerase (Novagen). Amplified products were cloned into pOPIN vectors (Berrow et al., 2007) using the In-Fusion HD system (Clontech). Mutagenesis was performed using the QuikChange protocol. Constructs for YopJ in pMW and AvrA in pGEX6P-1 were kind gifts from R. Mittal (MRC LMB Cambridge). Constructs for SENP1 and NEDP1 in pHISTEV were kinds gifts from R. Hay (University of Dundee). tSUMO was amplified from a Solanum lycopersicum cDNA preparation (kind gift from A. Canto-Pastor and D. Baulcombe, University of Cambridge) and ligated into pTXB1 with conventional methods.
Protein expression and purification
SseL (24-340), ChlaDUB1 (130-401), ElaD (2-407), ShiCE (2-405), RickCE (378-691 or 420-691), , and XopD (298-515 or 335-515) were expressed from the pOPIN-B vector (N-terminal His-3C), AvrA (1-288) from the pGEX6P-1 vector (N-terminal GST-3C), YopJ (1-288) from the pMW vector (Cterminal 3C-GST), and SENP1 (415-643), NEDP1 (2-212) from the pHISTEV vector (N-terminal His-TEV). The SseL 24-340 construct may represent the full-length sequence secreted by S. Typhimurium, depending on usage of an alternative GTG start codon at position 24. The SseL VHS domain construct, cloned into pOPIN-B, included residues 24-137 as well as an 'EQVGVENLWRD' C-terminal sequence designed using the crystal structure to reconstitute key stabilizing interactions made by the C-terminal catalytic domain. With the exception of YopJ, SENP1, NEDP1, and SseL VHS domain, all tags were cleaved as part of the purification. All constructs were transformed into the E. coli Rosetta2 pLacI strain. 2-12 L cultures were grown at 37˚C in 2xTY medium to an OD 600 of 0.8-1.0, at which time protein expression was induced with 0.2 mM IPTG for 16-20 h at 18˚C. Cells were resuspended in 25 mM Tris (pH 7.4), 200 mM NaCl, 2 mM ß-mercaptoethanol (Buffer A). Following freeze-thaw and addition of EDTA-free Complete protease inhibitor tablets (Roche), DNase, and Lysozyme, cells were lysed by sonication or using an Emulsiflex C3. Lysates were clarified by centrifugation at 35000 x g for 25 min, and applied to Talon (Clontech) or Glutathione Sepharose 4B (GE Healthcare) resin for gravity flow purification according to manufacturer recommendations. His-tagged proteins were washed thoroughly with Buffer A, eluted in Buffer A with 250 mM imidazole, and (with the exception of SENP1 and NEDP1) the tag was cleaved overnight with His-3C protease during dialysis back to Buffer A. Cleaved protein was reapplied to Talon resin and flow-through was collected for further purification. GST-tagged proteins were washed thoroughly with Buffer B (25 mM Tris (pH 8.5), 5 mM DTT)) plus 500 mM NaCl, then Buffer B plus 50 mM NaCl, prior to elution with 10 mM GSH (in the case of YopJ) or overnight cleavage with addition of GST-3C protease. When required, cleaved proteins were exchanged into Buffer B plus 50 mM NaCl and applied to anion exchange chromatography (ResourceQ 6 mL, GE Healthcare), followed by elution with a 50-500 mM NaCl gradient. The SseL VHS domain was purified from inclusion bodies. Following solubilization in Buffer A plus 8 M Urea, 10 mM NH 4 Cl, SseL VHS domain was bound to gravity flow Ni 2+ resin (Qiagen), refolded using a gradient to Buffer A without Urea, and eluted in Buffer A plus 250 mM imidazole. All proteins were subjected to final gel filtration (Superdex75, GE Healthcare) equilibrated in 25 mM HEPES (pH 8.0), 150 mM NaCl, 5 mM DTT. Protein-containing fractions were concentrated, aliquoted, and flash-frozen prior to storage at -80˚C.
TAMRA-based cleavage assays
All Ub/Ubl-TAMRA-KG reagents were prepared as previously described (Geurink et al., 2012; Basters et al., 2014) , with the exception of the tSUMO-TAMRA-KG reagent, which was prepared as follows:
Native chemical ligation tSUMO-MesNa (aa 1-96, 4.0 mg, 0.37 µmol), prepared as previously described (Borodovsky et al., 2002) , and TMR-Lys(thio)G (4.0 mg, 5.4 µmol) were dissolved in 200 µL of aqueous buffer containing 6.0 M Gn·HCl, 0.15 M Na 2 HPO 4 and 0.25 M MPAA at pH 7.2 and shaken overnight at 37°C. The product was purified by RP-HPLC (Shimadzu, C18, 10-70% v/v ACN/H 2 O gradient, 0.05% v/v TFA). The appropriate fractions were pooled and lyophilized. Desulfurization The resulting product (ca. 4 mg) was dissolved in aqueous buffer containing 6.0 M Gn·HCl, 0.15 M Na 2 HPO 4 and 0.25 M TCEP at pH 7.0 to a concentration of 1 mg/mL protein. Reduced glutathione (GSH) was added to the solution to a concentration of 100 mM. The pH of the solution was adjusted to pH 7.0 by addition of 1 M NaOH. VA-044 was added to the solution to a final concentration of 75 mM. The reaction mixture was flushed with argon and shaken for 4 h at 37°C after which LC-MS analysis indicated a complete reaction. The product was purified by RP-HPLC (Shimadzu, C18, 10-70% v/v ACN/H 2 O gradient, 0.05% v/v TFA). The appropriate fractions were combined, lyophilized, dissolved in H 2 O/ACN/formic acid (65/35/10; v/v/v; 10 mL) and lyophilized again. Finally, the product was purified on a Superdex75 size exclusion column (GE Healthcare) equilibrated in 50 mM Tris (pH 7.6), 100 mM NaCl. This yielded 0.85 mg (75 nmol, 21%) of the tSUMO-TAMRA-KG substrate.
Fluorescence polarization (FP) assays monitoring cleavage of the Ub/Ubl substrates were performed as described previously (Geurink et al., 2012) . Briefly, enzymes and Ub/Ubl substrates were diluted in 25 mM Tris (pH 7.4), 100 mM NaCl, 5 mM ß-mercaptoethanol, 0.1 mg/mL BSA (FP buffer). Enzyme concentrations were varied to capture a representative activity profile, up to a maximum concentration of 150 nM. Substrate concentrations were held at 150 nM. Enzyme and substrate were mixed in black 384-well plates (Corning) immediately before the assay began. FP was measured in a Pherastar plate reader (BMG Labtech) equipped for 550 nm excitation and 590 nm emission. Cleavage measurements were normalized to independently measured negative (Ub/Ubl substrate only) and positive (25 nM TAMRA-KG peptide) control samples. All comparative data (Ub vs. Ubl, wild-type vs. mutant) are presented from one representative replicate.
Qualitative cleavage assays
Deubiquitination specificity assays were performed as described previously (Licchesi et al., 2012) . Enzymes were diluted to a 2x stock concentration in 25 mM Tris (pH 7.4), 150 mM NaCl, 10 mM DTT and combined 1:1 with 6 µM diUb prepared in 100 mM Tris (pH 7.4), 100 mM NaCl, 10 mM DTT. Reactions were incubated at 37˚C, time points were resolved by SDS-PAGE and silver stained (BioRad). Pro-NEDD8 (Boston Biochem) and Cul1-NEDD8 (kind gift from B. Schulman, St. Jude Children's Research Hospital) cleavage assays were performed with the same protocol.
Acetylation assays
Enzymes were diluted to 5 µM in 25 mM HEPES (pH 8.0), 50 mM NaCl, 200 nM inositol hexakisphosphate (IP6), 0.5 mM DTT and incubated with 60 µM [1-
14 C] AcCoA (60 mCi/mmol, PerkinElmer) at 37˚C for 2 h. Reactions were resolved by SDS-PAGE. The gel was dried and exposed to a Phosphor screen, which was then imaged on a Typhoon scanner (GE Healthcare). In our assays, catalytically inactive mutants, as well as unrelated protein standards (not shown), can be non-enzymatically modified by AcCoA. Therefore, only an increased signal in wild-type assays compared to the catalytically inactive controls should be considered true acetylation activity.
Suicide probe assays
Ub-and Ubl-PA probes were generated as described previously (Ekkebus et al., 2013) , with exception of tSUMO-PA and all Ub/tSUMO-PA point mutants, which were prepared according to (Borodovsky et al., 2002) with propargylamine. Assays testing Ub/NEDD8 specificity were performed using suicide probes prepared from 2-chloroethylamine, as described previously (Borodovsky et al., 2002) . Enzymes were diluted to 10 µM in 25 mM Tris (pH 7.4), 150 mM NaCl, 10 mM DTT, and combined 1:1 with 100 µM probe. Reactions were incubated at room temperature or on ice (as specified), time points were resolved by SDS-PAGE and Coomassie stained.
Protein crystallization
Initial hits were obtained using commercial screens in the sitting-drop vapor diffusion format. Native and SeMet His-SseL (24-340) were prepared in 25 mM Tris (pH 7.4), 200 mM NaCl, 2 mM ß-mercaptoethanol and crystallized at 14 mg/mL in 0.1 M Tris, 1.6 M K 2 HPO 4 (final pH 8.7), with a 1 µL sitting drop at 2:1 protein:precipitant ratio. SseL crystals were cryoprotected in ParatoneN (native crystals) or paraffin oil (SeMet crystals). Native ChlaDUB1 (130-401) was prepared in 25 mM Tris (pH 7.4), 125 mM NaCl, 4 mM DTT and crystallized at 12 mg/mL in 0.1 M HEPES (pH 7.5), 20% PEG 8000, with a 400 nL sitting drop at 1:1 protein:precipitant ratio. SeMet ChlaDUB1 was crystallized at 8 mg/mL in a 1 µL sitting drop of the matched condition, using seeds of native crystals. Crystals were cryoprotected using mother liquor containing 22-25% glycerol. Native RickCE (420-691) was prepared in 25 mM Tris (pH 7.4), 125 mM NaCl, 4 mM DTT and crystallized by hanging drop, mixing 2 µL of 13 mg/mL protein with 1 µL of 0.1 M Tris (pH 7.5), 2 M ammonium citrate. SeMet RickCE was crystallized the same manner, using native RickCE crystals as seeds. Crystals either had no cryoprotectant (SeMet RickCE), or were cryoprotected with mother liquor containing 22-25% glycerol. The XopD~Ub complex was prepared in 25 mM Tris (pH 7.4), 125 mM NaCl, 4 mM DTT and crystallized at 12 mg/mL in 0.1 M CHES (pH 9.5), 1.0 M sodium citrate, with a 200 nL sitting drop at 1:1 protein:precipitant ratio. Crystals were cryocooled with no protectant. The XopD~tSUMO complex was prepared similarly, and
